VERICEL CORPORATION Other Current Liabilities
VERICEL CORPORATION (VCEL) had Other Current Liabilities of $116.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-07-30
- 2026-06-30: Other Liabilities, Current $116.00K.
- 2026-03-31: Other Liabilities, Current $116.00K.
- 2025-12-31: Other Liabilities, Current $116.00K.
- 2025-09-30: Other Liabilities, Current $116.00K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $116.00K 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $116.00K 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $116.00K 10-Q · filed 2026-07-30 | |
| 2025-09-30 | $116.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $118.00K 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $116.00K 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $116.00K 10-K · filed 2026-02-26 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $21.00K 10-Q · filed 2023-08-02 | |
| 2023-03-31 | $20.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $41.00K 10-K · filed 2024-02-29 | |
| 2022-09-30 | $41.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $41.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $41.00K 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $41.00K 10-K · filed 2023-02-23 | |
| 2021-09-30 | $41.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $41.00K 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $41.00K 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $41.00K 10-K · filed 2022-02-24 | |
| 2020-09-30 | $41.00K 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $41.00K 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $41.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $41.00K 10-K · filed 2021-02-24 | |
| 2019-09-30 | $35.00K 10-Q · filed 2019-11-05 | |
| 2019-06-30 | $34.00K 10-Q · filed 2019-08-06 | |
| 2019-03-31 | $176.00K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $754.00K 10-K · filed 2020-02-25 | $188.00K 10-K · filed 2019-02-26 |
| 2018-09-30 | $189.00K 10-Q · filed 2018-11-06 | |
| 2018-06-30 | $198.00K 10-Q · filed 2018-08-06 | |
| 2018-03-31 | $159.00K 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $181.00K 10-K · filed 2019-02-26 | |
| 2017-09-30 | $216.00K 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $215.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $291.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $256.00K 10-K · filed 2018-03-05 | $259.00K 10-K · filed 2017-03-13 |
| 2016-09-30 | $39.00K 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $39.00K 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $136.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $160.00K 10-K · filed 2017-03-13 | |
| 2015-09-30 | $130.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $154.00K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $180.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $210.00K 10-K · filed 2016-03-14 | |
| 2013-12-31 | $6.00K 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |